Xing Chang

103 Wenhua Road
Shenyang, 110016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.

Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.

Journal: Biochemical pharmacology

Published: April 07, 2023

Differential privacy protection algorithm for network sensitive information based on singular value decomposition.

Differential privacy protection algorithm for network sensitive information based on singular value decomposition.

Journal: Scientific reports

Published: December 21, 2022

FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells.

FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells.

Journal: Medical oncology (Northwood, London, England)

Published: October 04, 2022

A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers.

A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers.

Journal: The Journal of biological chemistry

Published: March 22, 2022

1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells.

1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells.

Journal: Toxicology and applied pharmacology

Published: March 10, 2022

FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene.

FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene.

Journal: Cell

Published: December 23, 2021

Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors.

Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: November 17, 2021

Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.

Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.

Journal: Toxicology and applied pharmacology

Published: August 17, 2021

The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy.

The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy.

Journal: European journal of pharmacology

Published: September 17, 2020

A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy.

A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy.

Journal: Toxicology and applied pharmacology

Published: May 24, 2019

Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer.

Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer.

Journal: Cancer chemotherapy and pharmacology

Published: May 21, 2019

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.

Journal: Cancer biology & therapy

Published: December 06, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026